118 related articles for article (PubMed ID: 20228273)
1. Polyphosphate modifies the fibrin network and down-regulates fibrinolysis by attenuating binding of tPA and plasminogen to fibrin.
Mutch NJ; Engel R; Uitte de Willige S; Philippou H; Ariëns RA
Blood; 2010 May; 115(19):3980-8. PubMed ID: 20228273
[TBL] [Abstract][Full Text] [Related]
2. The effect of plasmin-mediated degradation on fibrinolysis and tissue plasminogen activator diffusion.
Bannish BE; Paynter B; Risman RA; Shroff M; Tutwiler V
Biophys J; 2024 Mar; 123(5):610-621. PubMed ID: 38356261
[TBL] [Abstract][Full Text] [Related]
3. Plasma-based assays distinguish hyperfibrinolysis and shutdown subgroups in trauma-induced coagulopathy.
Lawson MA; Holle LA; Dow NE; Hennig G; de Laat B; Moore HB; Moore EE; Cohen MJ; Bouchard BA; Freeman K; Wolberg AS
J Trauma Acute Care Surg; 2022 Nov; 93(5):579-587. PubMed ID: 35687811
[TBL] [Abstract][Full Text] [Related]
4. Co-ordinated spatial propagation of blood plasma clotting and fibrinolytic fronts.
Zhalyalov AS; Panteleev MA; Gracheva MA; Ataullakhanov FI; Shibeko AM
PLoS One; 2017; 12(7):e0180668. PubMed ID: 28686711
[TBL] [Abstract][Full Text] [Related]
5. Inherent fibrin fiber tension propels mechanisms of network clearance during fibrinolysis.
Cone SJ; Fuquay AT; Litofsky JM; Dement TC; Carolan CA; Hudson NE
Acta Biomater; 2020 Apr; 107():164-177. PubMed ID: 32105833
[TBL] [Abstract][Full Text] [Related]
6. Assays to quantify fibrinolysis: strengths and limitations. Communication from the International Society on Thrombosis and Haemostasis Scientific and Standardization Committee on fibrinolysis.
Zheng Z; Mukhametova L; Boffa MB; Moore EE; Wolberg AS; Urano T; Kim PY
J Thromb Haemost; 2023 Apr; 21(4):1043-1054. PubMed ID: 36759279
[TBL] [Abstract][Full Text] [Related]
7. Formation and elimination of soluble fibrin and D-dimer in the bloodstream.
Udovenko A; Makogonenko Y; Korolova D; Druzhyna N; Chernyshenko V; Komisarenko S
Croat Med J; 2023 Dec; 64(6):421-429. PubMed ID: 38168523
[TBL] [Abstract][Full Text] [Related]
8. Fibrinogen counteracts the antiadhesive effect of fibrin-bound plasminogen by preventing its activation by adherent U937 monocytic cells.
Lishko VK; Yermolenko IS; Owaynat H; Ugarova TP
J Thromb Haemost; 2012 Jun; 10(6):1081-90. PubMed ID: 22507544
[TBL] [Abstract][Full Text] [Related]
9. The fibrinolysis renaissance.
Mutch NJ; Medcalf RL
J Thromb Haemost; 2023 Dec; 21(12):3304-3316. PubMed ID: 38000850
[TBL] [Abstract][Full Text] [Related]
10. Fungi Fibrinolytic Compound 1 Plays a Core Role in Modulating Fibrinolysis, Altering Plasma Clot Structure, and Promoting Susceptibility to Lysis.
Gao C; Bao B; Bao C; Wu W
Pharmaceutics; 2023 Sep; 15(9):. PubMed ID: 37765289
[TBL] [Abstract][Full Text] [Related]
11. Synergism of red blood cells and tranexamic acid in the inhibition of fibrinolysis.
Raska A; Kálmán K; Egri B; Csikós P; Beinrohr L; Szabó L; Tenekedjiev K; Nikolova N; Longstaff C; Roberts I; Kolev K; Wohner N
J Thromb Haemost; 2024 Mar; 22(3):794-804. PubMed ID: 38016517
[TBL] [Abstract][Full Text] [Related]
12. Identification of potent anti-fibrinolytic compounds against plasminogen and tissue-type plasminogen activator employing
Banerjee S; Mahesh Y; Prabhu D; Sekar K; Sen P
J Biomol Struct Dyn; 2024 Apr; 42(6):3204-3222. PubMed ID: 37216286
[TBL] [Abstract][Full Text] [Related]
13. Fibrinolysis: A Primordial System Linked to the Immune Response.
Medcalf RL; Keragala CB
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33810275
[TBL] [Abstract][Full Text] [Related]
14. Fibrin is a critical regulator of neutrophil effector function at the oral mucosal barrier.
Silva LM; Doyle AD; Greenwell-Wild T; Dutzan N; Tran CL; Abusleme L; Juang LJ; Leung J; Chun EM; Lum AG; Agler CS; Zuazo CE; Sibree M; Jani P; Kram V; Martin D; Moss K; Lionakis MS; Castellino FJ; Kastrup CJ; Flick MJ; Divaris K; Bugge TH; Moutsopoulos NM
Science; 2021 Dec; 374(6575):eabl5450. PubMed ID: 34941394
[TBL] [Abstract][Full Text] [Related]
15. Biophysical Mechanisms Mediating Fibrin Fiber Lysis.
Hudson NE
Biomed Res Int; 2017; 2017():2748340. PubMed ID: 28630861
[TBL] [Abstract][Full Text] [Related]
16. Common fibrin deposition and tissue plasminogen activator downregulation in nasal polyps with distinct inflammatory endotypes.
Chen CL; Yao Y; Pan L; Hu ST; Ma J; Wang ZC; Kern RC; Schleimer RP; Liu Z
J Allergy Clin Immunol; 2020 Sep; 146(3):677-681. PubMed ID: 32112792
[No Abstract] [Full Text] [Related]
17. Connecting impaired fibrinolysis and dyslipidemia.
Rodriguez M; Zheng Z
Res Pract Thromb Haemost; 2024 Mar; 8(3):102394. PubMed ID: 38706781
[TBL] [Abstract][Full Text] [Related]
18. Polyphosphate as a haemostatic modulator.
Mutch NJ
Biochem Soc Trans; 2016 Feb; 44(1):18-24. PubMed ID: 26862183
[TBL] [Abstract][Full Text] [Related]
19. Global hemostasis assays in acute myeloid leukemia: results of an observational prospective study.
Raso S; Lucchesi A; Sardo M; Annibali O; Sucato V; Ciaccio M; Vitale S; Dolce A; Giordano G; Siragusa S; Napolitano M
Blood Transfus; 2024 Jan; 22(1):65-74. PubMed ID: 37458717
[TBL] [Abstract][Full Text] [Related]
20. All tangled up: interactions of the fibrinolytic and innate immune systems.
Whyte CS
Front Med (Lausanne); 2023; 10():1212201. PubMed ID: 37332750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
